SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-090450
Filing Date
2023-08-11
Accepted
2023-08-11 16:00:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 tm2323336-3_424b3.htm 424B3 567148
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 29429
3 GRAPHIC tb_external-4clr.jpg GRAPHIC 75551
4 GRAPHIC tb_internal-4clr.jpg GRAPHIC 66998
5 GRAPHIC tb_material-4clr.jpg GRAPHIC 185719
6 GRAPHIC bc_developed-4clr.jpg GRAPHIC 113118
7 GRAPHIC bc_dipraglurant-4clr.jpg GRAPHIC 77529
  Complete submission text file 0001104659-23-090450.txt   1324115
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271611 | Film No.: 231163854
SIC: 2834 Pharmaceutical Preparations